Artiva Biotherapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +504.1% | +481.3% | -21.7% | -21.0% | +99.4% | -37.5% | |
| – | +1,230.7% | +521.6% | -35.5% | -23.7% | +136.3% | -40.3% | |
| – | +1,259.1% | +532.5% | -36.3% | -47.8% | -24.8% | -33.6% | |
| – | +1,259.1% | +532.5% | -36.3% | -24.9% | +140.9% | -41.8% | |
| – | – | – | +12.2% | +234.9% | -91.7% | +425.3% | |
| – | +477.3% | +409.4% | +5.8% | -2.4% | -91.4% | -8.6% | |
| – | +511.9% | +234.9% | +32.7% | -52.3% | +0.2% | +6.8% | |
| – | +120.2% | -5.5% | +705.1% | +3.2% | +4.0% | -18.2% | |
| – | +733.7% | -32.9% | -24.1% | -44.0% | +82.6% | -68.3% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -41.1% | |
| – | – | – | – | – | – | – | |
| – | – | +0.0% | +0.0% | +32.4% | +4.6% | +0.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.